Absci is a generative artificial intelligence (AI) drug creation company utilizing deep learning and synthetic biology for therapeutic potential of proteins. Co. utilizes its integrated drug creation platform to identify drug targets and create biotherapeutic candidates. Co.'s Integrated Drug Creation platform combines: the data to train, in which its SoluPro technology constructs genetically-distinct cells; the AI to Create, which designs new therapeutic candidates using generative AI models; and the wet lab to validate, which supports its generative AI designs with its wet lab's throughput functional validation capabilities. We show 11 historical shares outstanding datapoints in our ABSI shares outstanding history coverage, used to compute ABSI market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ABSI market cap history over the course of time is important for investors
interested in comparing ABSI's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ABSI versus a peer is one thing; comparing
ABSI market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ABSI can fluctuate over the course of history.
With this page we aim to empower investors researching ABSI by allowing them to research the ABSI market cap history. |
Free ABSI Email Alerts:
Video: The Importance of Market Cap
